Ben Franklin Honored with Local Venture Impact Award at Philadelphia Business Journal’s 2011 Life Sciences Awards

Posted on October 6, 2011 in News & Announcements

PHILADELPHIA, PA (www.sep.benfranklin.org) – Today, Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) was honored with the Local Venture Impact Award at the Philadelphia Business Journal’s 2011 Life Sciences Awards.  The Award recognizes the venture capital firm that has had the most impact upon companies in the Philadelphia region.  Ben Franklin was the highest-ranking awardee in the category.

Jennifer Hartt, Ben Franklin’s Director of Investments, Life Sciences, accepted the award.

“Ben Franklin was the first economic development organization to support emerging Life Sciences companies in the region, and has become a proven investor, supporter and friend to them,” said RoseAnn B. Rosenthal, President and CEO of Ben Franklin.
Our congratulations to all the winners from Ben Franklin’s family of clients and partners, including both Jane H. Hollingsworth of NuPathe Inc. and Vincent Milano of ViroPharma Inc., for Life Sciences CEO of the Year Awards; and the University City Science Center, for the Judges’ Choice Award.
Now in its 28th year, Ben Franklin offers entrepreneurs and established businesses the Capital, Knowledge and Networks to compete in the global marketplace.

Ben Franklin has invested upwards of $75 million in the region to build research and development partnerships between universities and corporations, and grow companies in the Life Sciences sector.  Since 2000 alone, Ben Franklin has invested $16M+ in 32 companies, which have created or retained over a thousand jobs.

We invest across a span of technologies including: biopharmaceuticals, medical devices, diagnostics, biomaterials and healthcare IT.  We have funded and supported many of southeastern Pennsylvania’s leading and most promising life science companies, including Adolor, BioNanomatrix, Centocor, Cephalon, Immunotope, Immune Control, Jenrin, Molecular Detection, Morphotek, NuPathe, Orthovita, Protez and ViroPharma.

Ben Franklin’s Technology Commercialization Group (TCG) brings creative enterprises together with regional resources to get products to the marketplace faster.  Programs and partner initiatives include the Technology Commercialization Fund, The Nanotechnology Institute, Pennsylvania Biotechnology Center of Bucks County, Bridge Business Center, Pennsylvania Advanced Textile Research and Innovation Center (PATRIC), Pennsylvania Environmental Technologies for the Pharmaceutical Industry (PETPI), Wallace Coulter Translational Research Fund, University City Science Center’s QED Proof-of-Concept Funding Program, Health Innovation Partnership (HIP), and Fox Chase Cancer Center’s Innovators Fund.

 


 

About Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania is a national, award winning model for technology innovation, and a catalyst for Stimulating Entrepreneurial Potential.  For more than 28 years, we have invested in innovative enterprises and created commercialization pathways and partnerships that generate wealth through science and technology.  We offer entrepreneurs and established businesses the Capital, Knowledge and Networks to compete in the global marketplace.  We have invested more than $145 million to grow more than 1,700 regional enterprises across all areas of technology.

Ben Franklin’s programs and partnerships with universities, corporations and investors strengthen the region’s innovation infrastructure.  Together with partners across the region, we are fostering the formation of a Greater Philadelphia energy cluster…Power Valley.  We are the commercialization partner for the Greater Philadelphia Innovation Cluster (GPIC) national energy hub, and the founding partner of the Energy Commercialization Institute (ECI). We are founding partners of The Nanotechnology Institute (NTI), Emerald Stage2 Venture Fund, and numerous other programs and initiatives.

Ben Franklin is part of the Commonwealth of Pennsylvania’s Ben Franklin Technology Partnership.

For additional information, please visit www.sep.benfranklin.org, Facebook, LinkedIn & Twitter.

BFTP/SEP Contact:
Jaron J. Rhodes
Manager, Marketing and Communications
(215) 972-6700, ext. 3214
jaron@sep.benfranklin.org

MODANeat CompanyMolecular DetectionCoats AnalyticsClick EquationsClear AlignBioNano GenomicsScience CenterBio AdvanceDVIRCNFTEPennsylvania BIOPhilly Startup LeadersSELECT Greater Philadelphia